{"id":185241,"name":"THE ADVERTISING COALITION","slug":"the-advertising-coalition","state":"DC","description":"Coalition of trade associations and companies protecting advertising tax deductions.","totalSpending":1270000,"filings":11,"yearlySpending":[{"year":2018,"income":390000},{"year":2019,"income":560000},{"year":2020,"income":320000}],"firms":["POLSINELLI PC"],"lobbyists":["JAMES DAVIDSON","SYLVIA KORNEGAY"],"issues":["ADV"],"sampleDescriptions":["H.R.1776/ S.771, Improving Access To Affordable Prescription Drugs Act\nH.R. 2439/ S.1131, Fair Accountability and Innovative Research Drug Pricing Act\nS.1348, Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act\nH.R.4385, Responsibility in Drug Advertising Act \nH.R.4116, Transparent Drug Pricing Act\nS.2157, Drug-Price Transparency in Communications Act\nS.2478, End Taxpayer Subsidies for Drug Ads Act\nFTC Reauthorization Act of 2018 (Not introduced)","FTC Reauthorization Act of 2019 (Not introduced)\nS.73, End Taxpayer Subsidies for Drug Ads Act","FTC Reauthorization Act of 2019 (Not introduced)\nS.73, End Taxpayer Subsidies for Drug Ads Act\nS.1437, Drug-price Transparency in Communications (DTC) Act","FTC Reauthorization Act of 2019 (Not introduced)\nS.73, End Taxpayer Subsidies for Drug Ads Act\nS.1437, Drug-price Transparency in Communications (DTC) Act\nH.R. 4106, Responsibility in Drug Advertising Act","FTC Reauthorization Act of 2019 (Not introduced)\nS.73, End Taxpayer Subsidies for Drug Ads Act\nS.1437, Drug-price Transparency in Communications (DTC) Act\nH.R.4106, Responsibility in Drug Advertising Act\nH.R. 4711 - No Tax Breaks for Drug Ads Act \nS.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act \nS.1801 - Affordable Medications Act"],"years":[2018,2019,2020]}